Crossmark

Changing paradigms in bioequivalence trials submitted to the EMA for evaluation – A clinical and regulatory perspective

Published Print: 2017-02

Authors

Refalo, Nathaniel

Chetcuti, Daniel

Tanti, Amy

Serracino-Inglott, Anthony

Borg, John Joseph
License Information

Text and Data Mining valid from 2017-02-01

Version of Record valid from 2016-07-28
More Information

This article is maintained by: Elsevier

Article Title: Changing paradigms in bioequivalence trials submitted to the EMA for evaluation – A clinical and regulatory perspective

Journal Title: Saudi Pharmaceutical Journal

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jsps.2016.07.005

Content Type: article

Copyright: © 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University.

Document is current